ISLAMABAD: The recently held Pakistan-China B2B Investment Conference on Pharmaceuticals, Biotechnology and Healthcare managed to secure over $1.7 billion in investment commitments, state-run media reported on Monday, spanning agreements in vaccines, biologics, medical devices and other sectors.
The two-day conference, which opened on Friday in Islamabad, brought together Pakistani pharmaceutical, health care and biotechnology companies with Chinese investors, manufacturers, technology providers and industry leaders.
According to a report in the state-run Associated Press of Pakistan (APP) quoting Pakistan’s Ambassador to China Khalil Hashmi, enterprises from both countries signed more than 120 memoranda of understanding, joint ventures and commercial agreements valued at over $1.7 billion during the conference.
“The agreements span a wide range of sectors, including biotechnology, vaccines, biologics, active pharmaceutical ingredients (APIs), medical devices, pharmaceuticals, Traditional Chinese Medicine (TCM), clinical research, and other allied health care industries,” APP quoted Hashmi as saying.
Hashmi said the conference provided fresh momentum to Pakistan–China business collaboration by promoting investment, transfer of technology, industrial partnerships, and deeper economic integration between the pharmaceutical industries of the two countries.
“Looking ahead, Ambassador Hashmi said follow-up efforts will begin shortly to facilitate the conversion of signed MoUs into binding contracts and commercial agreements, with the ultimate goal of translating these commitments into operational factories, manufacturing plants, and long-term investment projects,” APP said.
Delegates at the conference engaged in structured B2B meetings, networking sessions, and investment discussions aimed at fostering joint ventures, technology transfer, contract manufacturing and research collaboration.
It took place at a time when Pakistan is trying to achieve economic stabilization under a $7 billion International Monetary Fund (IMF) program, with policymakers increasingly shifting their focus toward reviving industrial activity, attracting investment and increasing exports.
